Search research articles
Contact Us
Filters
Showing results (281-290 of 307) with videos related to
Page
of 31
Sort By:
The Prostate
|
August 26, 2021
The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first-line therapy for patients with metastatic castration-resistant prostate cancer
Zhipeng Wang, Sha Zhu, Jinge Zhao, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
December 8, 2016
Persistency of Enlarged Autolysosomes Underscores Nanoparticle-Induced Autophagy in Hepatocytes
Ji-Qian Zhang, Wei Zhou, Sha-Sha Zhu, et al.
Nature Communications
|
June 25, 2026
Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model
Fang Wan, Jinchen He, Hong Ma, et al.
The Prostate
|
May 24, 2021
Dynamic multidisciplinary team discussions can improve the prognosis of metastatic castration-resistant prostate cancer patients
Sha Zhu, Junru Chen, Yuchao Ni, et al.
Nature Communications
|
June 12, 2024
UBE2D3 facilitates NHEJ by orchestrating ATM signalling through multi-level control of RNF168
Zeliha Yalçin, Shiu Yeung Lam, Marieke H Peuscher, et al.
Cancer Letters
|
October 25, 2023
SETD4 inhibits prostate cancer development by promoting H3K27me3-mediated NUPR1 transcriptional repression and cell cycle arrest
Chong Wang, Tao Wang, Kang-Jing Li, et al.
The Prostate
|
July 12, 2019
AKR1C3 expression in primary lesion rebiopsy at the time of metastatic castration-resistant prostate cancer is strongly associated with poor efficacy of abiraterone as a first-line therapy
Jinge Zhao, Mengni Zhang, Jiandong Liu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 8, 2025
Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma in Children and Adolescents
Haoyang Liu, Haolin Liu, Junru Chen, et al.
ACS Central Science
|
October 27, 2025
Enzyme Activity-Based Genome-wide Screening for Modifiers of Lysosomal Glucocerebrosidase Uncovers Candidate Risk Factors for Parkinson's Disease
Vinod Udayar, Pierre-André Gilormini, Julien Bryois, et al.
Molecular Cancer
|
June 26, 2024
Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinoma
Junjie Zhao, Yanfeng Tang, Xu Hu, et al.
Page
of 31
Search research articles
Search
Showing results (281-290 of 307) with videos related to
Sort By:
Page
of 31
The Prostate
|
August 26, 2021
The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first-line therapy for patients with metastatic castration-resistant prostate cancer
Zhipeng Wang, Sha Zhu, Jinge Zhao, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
December 8, 2016
Persistency of Enlarged Autolysosomes Underscores Nanoparticle-Induced Autophagy in Hepatocytes
Ji-Qian Zhang, Wei Zhou, Sha-Sha Zhu, et al.
Nature Communications
|
June 25, 2026
Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model
Fang Wan, Jinchen He, Hong Ma, et al.
The Prostate
|
May 24, 2021
Dynamic multidisciplinary team discussions can improve the prognosis of metastatic castration-resistant prostate cancer patients
Sha Zhu, Junru Chen, Yuchao Ni, et al.
Nature Communications
|
June 12, 2024
UBE2D3 facilitates NHEJ by orchestrating ATM signalling through multi-level control of RNF168
Zeliha Yalçin, Shiu Yeung Lam, Marieke H Peuscher, et al.
Cancer Letters
|
October 25, 2023
SETD4 inhibits prostate cancer development by promoting H3K27me3-mediated NUPR1 transcriptional repression and cell cycle arrest
Chong Wang, Tao Wang, Kang-Jing Li, et al.
The Prostate
|
July 12, 2019
AKR1C3 expression in primary lesion rebiopsy at the time of metastatic castration-resistant prostate cancer is strongly associated with poor efficacy of abiraterone as a first-line therapy
Jinge Zhao, Mengni Zhang, Jiandong Liu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 8, 2025
Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma in Children and Adolescents
Haoyang Liu, Haolin Liu, Junru Chen, et al.
ACS Central Science
|
October 27, 2025
Enzyme Activity-Based Genome-wide Screening for Modifiers of Lysosomal Glucocerebrosidase Uncovers Candidate Risk Factors for Parkinson's Disease
Vinod Udayar, Pierre-André Gilormini, Julien Bryois, et al.
Molecular Cancer
|
June 26, 2024
Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinoma
Junjie Zhao, Yanfeng Tang, Xu Hu, et al.
Page
of 31